a physician a building location a clinical trial a department
menu
BCM - Baylor College of Medicine

Giving life to possible

Dan L. Duncan Cancer Center

News and Events

In the News

News Releases

Study links tumor recurrence to growth factor commonly used in high-risk neuroblastoma treatmentMay 12, 2015
Baylor researchers find a human growth factor that expands white blood cells in response to infection also acts on neuroblastoma cancer stem cells that are thought responsible for disease relapse.
IL-33 promotes colorectal cancer tumor-growing environment Apr 27, 2015
Researchers from Baylor College of Medicine have unlocked new clues about how the colorectal cancer tumor microenvironment is formed and regulated.
Baylor receives Avon Foundation grants for research, community care Apr 27, 2015
Baylor College of Medicine has received two new grants totaling $325,000 from the Avon Foundation for Women that will help its physicians and researchers continue to improve access to life-saving breast cancer prevention and treatment resources.
Enzyme cuts path for T-cells to fight solid tumorsApr 13, 2015
T-cells specifically engineered to express enzyme heparanase have an improved ability to infiltrate the extracellular matrix surrounding solid tumors.
Ellis receives ASCO award for contributions to breast cancer genomics research, mentorshipMar 23, 2015
Dr. Matthew Ellis has been named recipient of the 2015 American Society of Clinical Oncology’s Gianni Bonadonna Breast Cancer Award and Lecture.
First evaluation of HER2-specific ‘killer’ T cells in humansMar 23, 2015
A clinical trial has shown promise for a new type of immunotherapy treatment for patients with HER2-positive sarcoma and may extend to other types of cancer.
Incorporate genetic evaluation in familial colorectal cancer screening Mar 18, 2015
Have a family history of colorectal cancer? Incorporate a genetics evaluation into a more proactive screening approach.
Fusion gene provides a biological marker and clue for ovarian cancerMar 10, 2015
Baylor researchers find a fusion gene may provide a clue and a marker for identifying a sub-group of the most common form of ovarian cancer.
Baylor College of Medicine receives an additional $11 million in state cancer funding Feb 23, 2015
Baylor researchers receive nine new grants totaling $11.3 million in the latest round of funding awarded by the Cancer Prevention and Research Institute of Texas.
Coactivator forges pathway for prostate cancer metastatic survivalFeb 16, 2015
New finding could help define pathway to develop a drug against prostate cancer metastasis, according to researchers at Baylor.
Saving the heart after cancer treatmentFeb 9, 2015
Baylor experts say early screening and monitoring using echocardiograms could be the key to helping cancer survivors stay heart healthy.
Grant allows development of 'freeze-frame' proteins to study DNAJan 30, 2015
Baylor College of Medicine's Dr. Susan Rosenberg and colleagues awarded three-year $2 million grant from W.M. Keck Foundation.
First comprehensive Lung Institute in Texas offers hope along with world class team of experts Jan 16, 2015
Baylor College of Medicine and Baylor St. Luke’s Medical Center have developed the first comprehensive, multi-specialty Lung Institute in the state of Texas.
Study looks at effect of diet on prostate cancer progressionJan 9, 2015
Recent studies suggest that nutrients found primarily in vegetables and fruits can help lower the risk of prostate cancer.
Grant supports research on potential immunotherapy treatment for neuroblastomaDec 30, 2014

Dr. Leonid Metelitsa, named among inaugural recipients of the Bio-therapeutics Impact Award from Alex’s Lemonade Stand.

Obesity, acid reflux precursors for esophageal cancerDec 29, 2014

New review examines latest developments in the risk factors, pathologies, diagnosis and treatment of esophageal cancers.

Study further suggests combination targeted therapy without chemotherapy a good option for some HER2-positive breast cancerDec 12, 2014
New data further suggests combination targeted therapy without chemotherapy is a potential approach for certain HER-2-positive breast cancer.
Dr. Trey Westbrook named TAMEST 2015 Edith and Peter O’Donnell Award winner in medicine Dec 9, 2014
Baylor College of Medicine researcher Dr. Thomas “Trey” Westbrook tapped for prestigious honor given annually to one scientist across the state of Texas for outstanding innovation in medicine.
New study identifies first gene associated with familial gliomaDec 7, 2014
Baylor-led research identifies for the first time a gene associated with familial glioma, brain tumors that appear in two or more members of the same family.
'Wound response' of cancer stem cells may explain chemo-resistance in bladder cancerDec 3, 2014
A novel mechanism – similar to how normal tissue stem cells respond to wounding – might explain why bladder cancer stem cells actively contribute to chemo-resistance after multiple cycles of chemotherapy drug treatment.